Saira Ramasastry

Director

Saira Ramasastry (Director) filed 7 Form 4 reports in the trailing twelve months (0 purchases, 7 sales), most often in Mirum Pharmaceuticals, Inc. (MIRM). The largest single filing was $400K of MIRM (5,000 sh × $80.00, as filed), executed Dec 22 2025.

Add to watchlist

Return, ttmiAverage return per filing, trailing twelve months

–

no purchases on file

Delay-adjustediThe same average, entered at disclosure dates

–

returns measure stock purchases only

Filings, ttm

0 buys · 7 sells

Median delay

–

execution → disclosure

Volume, ttmiDollar value disclosed in the trailing twelve months

$1.8M

shares × price, as filed

Last traded

Jun 1

Filed Jun 2

Median ADV $83.1M across their filed names

Open performance→

Volume by month

Buys $0 Sells $3.5M

Shares × price, as filed · by filing month · past 24 months

Sectors filed on

Healthcare 7 filings

Sector per market data · by filing · past 12 months

Most traded names

MIRM

Mirum Pharmaceuticals, Inc. MIRM · 0 buys · 9 sells 9 filings

Recent filings

MIRMSALE Mirum Pharmaceuticals, Inc. View filing → $398K
3,977 sh × $100.00
Exec Jun 1
Filed Jun 2 · 5:30 PM ET MIRMSALE Mirum Pharmaceuticals, Inc. View filing → $219K
2,000 sh × $109.47
Exec May 15
Filed May 18 · 5:30 PM ET MIRMSALE Mirum Pharmaceuticals, Inc. View filing → $194K
2,000 sh × $96.90
Exec Apr 15
Filed Apr 16 · 5:30 PM ET MIRMSALE Mirum Pharmaceuticals, Inc. View filing → $182K
2,000 sh × $90.76
Exec Mar 16
Filed Mar 17 · 5:30 PM ET MIRMSALE Mirum Pharmaceuticals, Inc. View filing → $204K
2,000 sh × $102.09
Exec Feb 13
Filed Feb 17 · 5:30 PM ET MIRMSALE Mirum Pharmaceuticals, Inc. View filing → $182K
2,000 sh × $90.99
Exec Jan 15
Filed Jan 16 · 5:30 PM ET MIRMSALE Mirum Pharmaceuticals, Inc. View filing → $400K
5,000 sh × $80.00
Exec Dec 22 2025
Filed Dec 23 2025 · 5:30 PM ET MIRMSALE Mirum Pharmaceuticals, Inc. View filing → $1.3M
as filed
Exec Sep 8 2025
Filed Sep 10 2025 · 5:30 PM ET More filings →